Results 251 to 260 of about 9,409,602 (307)

Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasm. [PDF]

Blood Neoplasia
Raychaudhuri S, Gooley TA, Rasmussen A, Quach K, Gill E, Halpern AB, Appelbaum JS, Ghiuzeli CM, Hendrie PC, Cassaday RD, Walter RB, Percival MM.   +11 more
europepmc   +1 more source

Long-Term Oncological Outcomes of Granulocyte Colony-Stimulating Factor (G-CSF) Treatment in Gastrointestinal Cancers: A Systematic Review and Meta-Analysis. [PDF]

Cancers (Basel)
Fischer OW, Justesen TF, Gögenur DS, Madsen MT, Mortensen MB, Gögenur I, Orhan A.   +6 more
europepmc   +1 more source

Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response. [PDF]

J Clin Med
Mezzanotte V, Paterno G, Cerroni I, De Marchi L, Taka K, Buzzatti E, Mallegni F, Meddi E, Moretti F, Buccisano F, Maurillo L, Palmieri R, Gurnari C, Venditti A, Del Principe MI.   +14 more
europepmc   +1 more source

Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells. [PDF]

J Hematol Oncol
Pezzella M, Quintarelli C, Quadraccia MC, Sarcinelli A, Manni S, Iaffaldano L, Ottaviani A, Ciccone R, Camera A, D'Amore ML, Di Cecca S, Sinibaldi M, Guercio M, Aurigemma M, De Falco P, Fustaino V, Rota R, Pomella S, Cassandri M, Di Giannatale A, Agrati C, Bordoni V, Guarracino F, Massa M, Del Baldo G, Becilli M, Milano GM, Del Bufalo F, Locatelli F, De Angelis B.   +29 more
europepmc   +1 more source

G-CSF for Extensive STEMI. [PDF]

Circulation research, 2019
In the exploratory Phase II STEM-AMI (Stem Cells Mobilization in Acute Myocardial Infarction) trial, we reported that early administration of G-CSF (granulocyte colony-stimulating factor), in patients with anterior ST-segment-elevation myocardial infarction and left ventricular (LV) dysfunction after successful percutaneous coronary intervention, had ...
Achilli F., Pontone G., Bassetti B., Squadroni L., Campodonico J., Corrada E., Facchini C., Mircoli L., Esposito Giovanni, Scarpa D., Pidello S., Righetti S., Di Gennaro F., Guglielmo M., Muscogiuri G., Baggiano A., Limido A., Lenatti L., Di Tano G., Malafronte C., Soffici F., Ceseri M., Maggiolini S., Colombo G. I., Pompilio G.   +24 more
openaire   +4 more sources

Sweet's syndrome associated with G‐CSF

British Journal of Haematology, 1993
Summary. Sweet's syndrome (SS) developed in two patients with acute myeloid leukaemia (AML) treated with granulocyte colony stimulating factor (G‐CSF) for febrile neutropenia due to AML chemotherapy. Fever, painful skin and conjunctival lesions developed and neutrophilic infiltration was detected at biopsy specimens.
Paydas S., Sahin B., Seyrek E., Soylu M., Gonlusen G., Acar A., Tuncer I.   +6 more
core   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Kinetics of Autologous Stem Cell Mobilization Failure: Comparison of AMD3100/G-CSF, G-CSF, GM-/G-CSF, and Chemotherapy/G-CSF on Remobilization Success.

Blood, 2006
Abstract Background: No standard approach for the mobilization of peripheral hematologic stem and progenitor cells (HSPCs) has been established. High levels of circulating CD34+ cells, a surrogate marker for mobilization efficiency, are associated with less apheresis days.
John F. DiPersio, Angela Smith, Dianne Sempek, Albert Baker, Steven Jiang, Ravi Vij, Amanda Cashen, Peter Westervelt   +7 more
openaire   +1 more source

[G-CSF and G-CSF receptor].

Rinsho byori. The Japanese journal of clinical pathology, 1995
Relationship between leucocytosis and G-CSF blood concentration were examined. Increase in blood concentration of G-CSF of surgical patient and dialysis patient with leucocytosis were noticed. Determination of G-CSF receptor on leucocyte was performed by the flow cytometry using biotinylated G-CSF.
K, Saionji, T, Satoh, H, Tokuda, H, Watanabe, A, Ohsaka, K, Hiyoshi, W, Kurotani   +6 more
openaire   +1 more source

Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF

Blood, 2000
The mechanisms that regulate hematopoietic progenitor cell (HPC) mobilization from the bone marrow to blood have not yet been defined. HPC mobilization by granulocyte colony-stimulating factor (G-CSF), cyclophosphamide (CY), or interleukin-8 but not flt-3 ligand is markedly impaired in G-CSF receptor–deficient (G-CSFR–deficient) mice.
F, Liu, J, Poursine-Laurent, D C, Link
openaire   +2 more sources